Nova One Advisor
Exoskeleton Market Size to Hit USD 2,25 Billion by 2034

Exoskeleton Market Size (By Mobility: Mobile, Fixed/Stationary; By Technology: Powered, Non-powered; By Extremity: Upper Body, Lower Body, Full Body; By End-use: Healthcare, Military, Industry)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2025-2034

Status: Published Category: Healthcare Insight Code: 6166 Format: PDF / PPT / Excel

Exoskeleton Market Size and Forecast 2025 to 2034

According to Nova One Advisor, the global Exoskeleton market gathered revenue around USD 499.45 million in 2024 and market is set to grow USD 2.25 billion by the end of 2034 and is estimated to expand at a modest CAGR of  16.29% during the prediction period 2025 to 2034.

Growth Factors:

Rapidly growing global geriatric population, increasing incidences of road accidents, rising prevalence of stroke is boosting the adoption of exoskeleton products and driving the market growth. As per National Safety Council data estimates in March 2021, 42,060 individuals have died in road accidents in 2025 and accounted for an increase of 8% as compared to 2024. Furthermore, the market is expected to witness the emergence of smarter & more competent exoskeletons through the integration of artificial intelligence and machine learning algorithms.

The mobile exoskeleton segment dominated in 2024 and is anticipated to grow lucratively over the forthcoming years owing to the emergence of innovative mobile exoskeletons for the disabled communities and geriatric population. Although, high costs and complications associated with mobile systems are expected to restrain the segment growth. The powered technology segment dominated in 2024 owing to the widespread adoption of powered exoskeletons for rehabilitation aid in patients suffering from spinal cord injuries.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Exoskeleton market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Exoskeleton market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Exoskeleton market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Report Scope of Exoskeleton Market

Report Coverage Details
Market Size in 2025 USD 1.74 Billion
Market Size by 2034 USD 2.79 Billion
Growth Rate From 2025 to 2034 CAGR of 5.4%
Base Year 2024
Forecast Period 2025-2034
Segments Covered Mobility, Technology, Extremity, End use, Region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Key Companies Profiled Ekso Bionics; Hocoma; Lockheed Martin Corporation; Suit X (U.S. Bionics, Inc.); Rex Bionics Plc.; RB3D; ReWalk Robotics Ltd; Cyberdyne, Inc.; and ActiveLink (Panasonic Corporation).

By Mobility Analysis

The mobile segment dominated the market for exoskeleton and accounted for the largest revenue share of 60.7% and largest volume share of 61.7%. The mobile segment is anticipated to register the fastest growth rate over the forthcoming years. 

This significant market share and lucrative growth rate is attributable to the surge in demand for motor-equipped robots for aiding human body mechanics and rise in research and development activities.

Key participants are constantly introducing innovative solutions for various industries which support worker/user’s health, boost productivity, reduce fatigue, and minimize risks of serious injuries. The growth witnessed by stationary exoskeleton technologies is due to the growing usage of stationary system in rehabilitation centers.

Exoskeleton Market By Mobility, 2024-2034 (USD Million)

Year 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Mobile 0.375 0.436 0.507 0.590 0.686 0.799 0.929 1.081 1.258 1.463 1.703
Fixed/Stationary 0.125 0.145 0.168 0.195 0.227 0.264 0.306 0.355 0.413 0.479 0.556

By Technology Analysis

The powered technology segment dominated the market for exoskeleton and accounted for the largest revenue share of 74.7% and volume share of 67.6% owing to the rising implementation of powered exoskeleton solutions in several industries to enhance personal safety and boost productivity.

Non-powered or passive technology segment is anticipated to register the fastest growth rate over the forthcoming years owing to the growing number of innovative product launches. For instance, in December 2024, Hilti partnered with Ottobock SE to launch EXO-O1, a passive exoskeleton used by the construction industry. 

By Extremity Analysis

The lower body segment dominated the market for exoskeleton and accounted for the largest revenue share 43.3% and volume share of 53.5% owing to the alarming rise of lower body disabilities and growing adoption rates of exoskeleton products by paralyzed and geriatric population for stability, mobility, and weight-bearing capabilities.

The upper body segment is anticipated to register the fastest growth rate over the forthcoming years owing to the benefits provided by exoskeleton products in upper extremities such as supporting disabled communities and rehabilitation aid in post-stroke, neurological, or musculoskeletal impairments. 

By End-use Analysis

The healthcare segment dominated the market for exoskeleton and accounted for the largest revenue share of 51.3% and volume share of 51.8% owing to the rising incidence rate of Spinal Cord Injuries (SCIs), widespread adoption of these products and solutions in rehabilitation centers, and significant surge in treatment numbers are some of the key driving factors.

On the other hand, the industry segment is anticipated to register the fastest growth over the forthcoming years owing to the rising awareness levels towards the benefits associated with exoskeleton technologies in several industry applications and rapidly growing incidence rate of occupation-related injuries.

Exoskeleton Market By End-use, 2024-2034 (USD Million)

Year 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Healthcare 0.225 0.262 0.305 0.355 0.413 0.481 0.560 0.651 0.758 0.883 1.028
Military 0.150 0.174 0.202 0.235 0.273 0.317 0.369 0.428 0.498 0.578 0.672
Industry 0.125 0.145 0.169 0.196 0.228 0.264 0.307 0.357 0.415 0.482 0.560

By Regional Analysis

North America dominated the market for exoskeleton and accounted for the largest revenue share of 47.0% and volume share of 28.4% owing to the growing prevalence of disabled individuals, rising expenditure on research activities, growing public and private support, increasing number of partnerships & collaborations amongst key participants, and availability of technologically advanced products.

Asia Pacific is anticipated to register the fastest growth rate over the forthcoming years owing to growing patient pool requiring rehabilitation support. Developing & advancing healthcare infrastructure, availability of government support and funding are driving the development and growth of the market for exoskeleton in Asia Pacific.

Exoskeleton Market By Regional, 2024-2034 (USD Million)

Year 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America 0.175 0.204 0.237 0.276 0.321 0.374 0.436 0.507 0.591 0.688 0.801
Europe 0.125 0.145 0.169 0.196 0.228 0.265 0.308 0.357 0.415 0.483 0.561
Asia-Pacific 0.125 0.145 0.169 0.196 0.228 0.265 0.308 0.357 0.415 0.483 0.561
Latin America 0.040 0.046 0.054 0.063 0.073 0.085 0.098 0.114 0.133 0.154 0.179
Middle East & Africa (MEA) 0.035 0.041 0.047 0.055 0.064 0.074 0.086 0.100 0.116 0.135 0.157

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Exoskeleton Market include: Ekso Bionics; Hocoma; Lockheed Martin Corporation; Suit X (U.S. Bionics, Inc.); Rex Bionics Plc.; RB3D; ReWalk Robotics Ltd; Cyberdyne, Inc.; and ActiveLink (Panasonic Corporation)

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2021 to 2034 and covers subsequent region in its scope:

By Mobility 

  • Mobile
  • Fixed/Stationary

By Technology 

  • Powered
  • Non-powered

By Extremity

  • Upper Body
  • Lower Body
  • Full Body

By End-use 

  • Healthcare
  • Military
  • Industry

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

List of Figure

List of Tables

  • Table 1: U.S. Exoskeleton Market, by Mobility, 2024–2034

  • Table 2: U.S. Exoskeleton Market, by Technology, 2024–2034

  • Table 3: U.S. Exoskeleton Market, by Extremity, 2024–2034

  • Table 4: U.S. Exoskeleton Market, by End-use, 2024–2034

  • Table 5: Canada Exoskeleton Market, by Mobility, 2024–2034

  • Table 6: Canada Exoskeleton Market, by Technology, 2024–2034

  • Table 7: Canada Exoskeleton Market, by Extremity, 2024–2034

  • Table 8: Canada Exoskeleton Market, by End-use, 2024–2034

  • Table 9: Mexico Exoskeleton Market, by Mobility, 2024–2034

  • Table 10: Mexico Exoskeleton Market, by Technology, 2024–2034

  • Table 11: Mexico Exoskeleton Market, by Extremity, 2024–2034

  • Table 12: Mexico Exoskeleton Market, by End-use, 2024–2034

  • Table 13: Germany Exoskeleton Market, by Mobility, 2024–2034

  • Table 14: Germany Exoskeleton Market, by Technology, 2024–2034

  • Table 15: Germany Exoskeleton Market, by Extremity, 2024–2034

  • Table 16: Germany Exoskeleton Market, by End-use, 2024–2034

  • Table 17: France Exoskeleton Market, by Mobility, 2024–2034

  • Table 18: France Exoskeleton Market, by Technology, 2024–2034

  • Table 19: France Exoskeleton Market, by Extremity, 2024–2034

  • Table 20: France Exoskeleton Market, by End-use, 2024–2034

  • Table 21: UK Exoskeleton Market, by Mobility, 2024–2034

  • Table 22: UK Exoskeleton Market, by Technology, 2024–2034

  • Table 23: UK Exoskeleton Market, by Extremity, 2024–2034

  • Table 24: UK Exoskeleton Market, by End-use, 2024–2034

  • Table 25: Italy Exoskeleton Market, by Mobility, 2024–2034

  • Table 26: Italy Exoskeleton Market, by Technology, 2024–2034

  • Table 27: Italy Exoskeleton Market, by Extremity, 2024–2034

  • Table 28: Italy Exoskeleton Market, by End-use, 2024–2034

  • Table 29: Rest of Europe Exoskeleton Market, by Segments, 2024–2034

  • Table 30: China Exoskeleton Market, by Mobility, 2024–2034

  • Table 31: China Exoskeleton Market, by Technology, 2024–2034

  • Table 32: China Exoskeleton Market, by Extremity, 2024–2034

  • Table 33: China Exoskeleton Market, by End-use, 2024–2034

  • Table 34: Japan Exoskeleton Market, by Mobility, 2024–2034

  • Table 35: Japan Exoskeleton Market, by Technology, 2024–2034

  • Table 36: Japan Exoskeleton Market, by Extremity, 2024–2034

  • Table 37: Japan Exoskeleton Market, by End-use, 2024–2034

  • Table 38: South Korea Exoskeleton Market, by Mobility, 2024–2034

  • Table 39: South Korea Exoskeleton Market, by Technology, 2024–2034

  • Table 40: South Korea Exoskeleton Market, by Extremity, 2024–2034

  • Table 41: South Korea Exoskeleton Market, by End-use, 2024–2034

  • Table 42: India Exoskeleton Market, by Mobility, 2024–2034

  • Table 43: India Exoskeleton Market, by Technology, 2024–2034

  • Table 44: India Exoskeleton Market, by Extremity, 2024–2034

  • Table 45: India Exoskeleton Market, by End-use, 2024–2034

  • Table 46: Southeast Asia Exoskeleton Market, by Segments, 2024–2034

  • Table 47: Rest of Asia Pacific Exoskeleton Market, by Segments, 2024–2034

  • Table 48: Brazil Exoskeleton Market, by Mobility, 2024–2034

  • Table 49: Brazil Exoskeleton Market, by Technology, 2024–2034

  • Table 50: Brazil Exoskeleton Market, by Extremity, 2024–2034

  • Table 51: Brazil Exoskeleton Market, by End-use, 2024–2034

  • Table 52: Rest of Latin America Exoskeleton Market, by Segments, 2024–2034

  • Table 53: GCC Countries Exoskeleton Market, by Mobility, 2024–2034

  • Table 54: GCC Countries Exoskeleton Market, by Technology, 2024–2034

  • Table 55: GCC Countries Exoskeleton Market, by Extremity, 2024–2034

  • Table 56: GCC Countries Exoskeleton Market, by End-use, 2024–2034

  • Table 57: Turkey Exoskeleton Market, by Segments, 2024–2034

  • Table 58: Africa Exoskeleton Market, by Segments, 2024–2034

  • Table 59: Rest of MEA Exoskeleton Market, by Segments, 2024–2034

List of Figures

  • Figure 1: U.S. Exoskeleton Market Share, by Mobility, 2024–2034

  • Figure 2: U.S. Exoskeleton Market Share, by Technology, 2024–2034

  • Figure 3: U.S. Exoskeleton Market Share, by Extremity, 2024–2034

  • Figure 4: U.S. Exoskeleton Market Share, by End-use, 2024–2034

  • Figure 5: Canada Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 6: Mexico Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 7: Germany Exoskeleton Market Share, by Mobility, 2024–2034

  • Figure 8: France Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 9: UK Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 10: Italy Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 11: China Exoskeleton Market Share, by Mobility, 2024–2034

  • Figure 12: Japan Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 13: South Korea Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 14: India Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 15: Brazil Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 16: GCC Countries Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 17: Turkey Exoskeleton Market Share, by Segments, 2024–2034

  • Figure 18: Africa Exoskeleton Market Share, by Segments, 2024–2034

  • Insight Code: 6166
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Recently Viewed Reports

FAQ's

The global exoskeleton market is expected to grow from USD 1.74 billion in 2025 to USD 2.79 billion by 2034, at a CAGR of 5.4%. This growth is driven by an aging population, rising stroke and spinal cord injuries, and industrial adoption for worker safety.

Key growth drivers include: Aging population needing mobility support. Rising cases of spinal cord injuries and strokes. Growing industrial applications to reduce workplace injuries. AI and machine learning integration enabling smarter exoskeletons.

Mobility: Mobile exoskeletons held 60.7% share in 2024 and will expand rapidly due to use in healthcare and rehabilitation. Technology: Powered exoskeletons dominated with 74.7% share, but passive/non-powered devices will see the fastest growth due to cost efficiency (e.g., EXO-O1 by Hilti & Ottobock in 2024). End-use: Healthcare leads today (51.3% share), but industrial applications are emerging fastest as companies adopt exoskeletons for workplace safety and productivity.

COVID-19 disrupted supply chains and temporarily slowed adoption, but it accelerated healthcare-focused R&D and rehabilitation applications. The long-term impact is positive as governments and private players invest more in robotics, AI-driven rehabilitation, and worker safety technologies.

North America (47% share in 2024) leads due to advanced R&D, government funding, and early adoption in healthcare and defense. Asia Pacific is expected to grow fastest, supported by a large rehabilitation patient pool, government support, and increasing industry demand (e.g., Japan, China, India). Europe remains strong due to active players in rehabilitation robotics and workplace safety initiatives.